Dynamic perioperative NPAR change for early identification of infectious complications after percutaneous nephrolithotomy: development and internal validation of a simple diagnostic model.
- 1Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
- 2College of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Abstract
Infectious complications are the most closely monitored adverse events after percutaneous nephrolithotomy (PCNL), and static single-timepoint markers stratify risk poorly. We evaluated whether the perioperative change in the neutrophil-percentage-to-albumin ratio (ΔNPAR), derived entirely from routine blood tests, identifies patients at higher risk of infectious complications within the first postoperative day. We retrospectively studied 339 patients (development cohort, South Campus, n=244; validation cohort, North Campus, n=95). The outcome was a predefined infectious complication after PCNL, ascertained at 24 h. The dynamic NPAR change was calculated as the postoperative minus preoperative difference (ΔNPAR = postoperative - preoperative NPAR). Because the candidate variables and the outcome were ascertained at the same 24-h assessment, the model is diagnostic rather than prognostic in design. A four-variable logistic model (female sex, diabetes, 24-h white blood cell count and ΔNPAR) was developed, internally validated by bootstrap resampling and penalized (Firth) regression, tested for robustness by propensity-score matching and decision-curve analysis, and then applied unchanged to the North Campus. All four factors were independently associated with the outcome (all P<0.05): female sex [adjusted odds ratio 6.30, 95% confidence interval (CI) 2.44-16.28], diabetes (3.26, 1.29-8.28), 24-h white blood cell count (1.19, 1.04-1.36) and ΔNPAR (per 1 standard deviation 2.47, 1.56-3.93). The model discriminated well in the development cohort [area under the curve (AUC) 0.868, 95% CI: 0.812-0.923], with minimal optimism after bootstrap correction (0.854), adequate calibration (Hosmer-Lemeshow P=0.26) and a positive net benefit across threshold probabilities of approximately 5-60%. At the Youden-optimal threshold, sensitivity was 96.9% and the negative predictive value (NPV) was 99.2%. Discrimination was maintained on the North Campus (AUC 0.896, 95% CI: 0.811-0.981; NPV 98.2%). Penalized regression and propensity-score matching reproduced the same associations. Preoperative NPAR did not differ between groups (P=0.73), indicating that the discriminative signal arose specifically from the perioperative dynamic change rather than from any baseline difference. A simple four-variable diagnostic model built on the dynamic change in NPAR identified PCNL patients with early infectious complications, showing good discrimination, a positive net benefit and a high NPV that could support earlier discharge or de-escalation of care for low-risk patients. All inputs are obtained from routine perioperative blood tests at no additional cost. Because the variables and the outcome are ascertained at the same assessment, the model performs contemporaneous risk stratification and early identification; it does not forecast a later event, and external multicentre validation against a culture-confirmed endpoint is warranted.
Related
- Gentamicin-Augmented Intrarenal Irrigation During Percutaneous Nephrolithotomy Reduces 30-Day Infectious Complications and Eliminates Pyelonephritis and Sepsis: A 1:2 Matched Cohort Study
- Impact of preoperative ureteral stenting on perioperative outcomes in percutaneous nephrolithotomy.
- Lung ultrasound-guided protocolized fluid management versus conventional central venous pressure-based management in monitoring extravascular lung water during the perioperative period of percutaneous nephrolithotomy: a randomized controlled trial.
- Safety and complications of upper pole puncture in supine percutaneous nephrolithotomy.
- Editorial comment: Craniocaudal bull's eye technique for superior calyceal access during percutaneous nephrolithotomy: Determination of angle, efficacy, and outcomes.
BibTeX
@article{liang2026dynamic,
title = {{Dynamic perioperative NPAR change for early identification of infectious complications after percutaneous nephrolithotomy: development and internal validation of a simple diagnostic model.}},
author = {Fuchao Liang and Chen Ding and Bin Chen and Guangyuan Yang and Dongcao Liu and Linghui Qin},
journal = {Translational andrology and urology},
year = {2026},
month = sep,
doi = {10.21037/tau-2026-0687},
url = {https://europepmc.org/article/MED/42997113},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Dynamic perioperative NPAR change for early identification of infectious complications after percutaneous nephrolithotomy: development and internal validation of a simple diagnostic model.
AU - Fuchao Liang
AU - Chen Ding
AU - Bin Chen
AU - Guangyuan Yang
AU - Dongcao Liu
AU - Linghui Qin
PY - 2026
DA - 2026/09/28
JO - Translational andrology and urology
DO - 10.21037/tau-2026-0687
UR - https://europepmc.org/article/MED/42997113
AB - Infectious complications are the most closely monitored adverse events after percutaneous nephrolithotomy (PCNL), and static single-timepoint markers stratify risk poorly. We evaluated whether the perioperative change in the neutrophil-percentage-to-albumin ratio (ΔNPAR), derived entirely from routine blood tests, identifies patients at higher risk of infectious complications within the first postoperative day. We retrospectively studied 339 patients (development cohort, South Campus, n=244; validation cohort, North Campus, n=95). The outcome was a predefined infectious complication after PCNL, ascertained at 24 h. The dynamic NPAR change was calculated as the postoperative minus preoperative difference (ΔNPAR = postoperative - preoperative NPAR). Because the candidate variables and the outcome were ascertained at the same 24-h assessment, the model is diagnostic rather than prognostic in design. A four-variable logistic model (female sex, diabetes, 24-h white blood cell count and ΔNPAR) was developed, internally validated by bootstrap resampling and penalized (Firth) regression, tested for robustness by propensity-score matching and decision-curve analysis, and then applied unchanged to the North Campus. All four factors were independently associated with the outcome (all P<0.05): female sex [adjusted odds ratio 6.30, 95% confidence interval (CI) 2.44-16.28], diabetes (3.26, 1.29-8.28), 24-h white blood cell count (1.19, 1.04-1.36) and ΔNPAR (per 1 standard deviation 2.47, 1.56-3.93). The model discriminated well in the development cohort [area under the curve (AUC) 0.868, 95% CI: 0.812-0.923], with minimal optimism after bootstrap correction (0.854), adequate calibration (Hosmer-Lemeshow P=0.26) and a positive net benefit across threshold probabilities of approximately 5-60%. At the Youden-optimal threshold, sensitivity was 96.9% and the negative predictive value (NPV) was 99.2%. Discrimination was maintained on the North Campus (AUC 0.896, 95% CI: 0.811-0.981; NPV 98.2%). Penalized regression and propensity-score matching reproduced the same associations. Preoperative NPAR did not differ between groups (P=0.73), indicating that the discriminative signal arose specifically from the perioperative dynamic change rather than from any baseline difference. A simple four-variable diagnostic model built on the dynamic change in NPAR identified PCNL patients with early infectious complications, showing good discrimination, a positive net benefit and a high NPV that could support earlier discharge or de-escalation of care for low-risk patients. All inputs are obtained from routine perioperative blood tests at no additional cost. Because the variables and the outcome are ascertained at the same assessment, the model performs contemporaneous risk stratification and early identification; it does not forecast a later event, and external multicentre validation against a culture-confirmed endpoint is warranted.
SN - 2223-4691
ER -